Global Health Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN L85110DL2004PLC128319 Incorporated 13 August 2004 ROC Delhi HQ New Delhi, Delhi, India
Active Listed - NSE: MEDANTA · BSE: 543654 Public Limited Company healthcare Nifty 500
Market Cap
₹38,831 Cr
MEDANTA · NSE
Share Price
₹1,436.60
-0.53% today
Revenue
₹4,410 Cr
FY 2025-26 · +19.4% YoY
EBITDA
₹909 Cr
Margin 20.6%
Net Profit
₹557 Cr
FY 2025-26 · +7.5% YoY
P/E (TTM)
59.5x
P/B 8.9x
ROE
15.1%
ROCE 16.8%
Debt / Equity
0.26
Interest cover 13.1x

About Global Health Limited

Data last updated:

Global Health Limited is a public limited company based in New Delhi, Delhi, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 13 August 2004 and has been in existence for over 22 years.

Global Health is part of the Nifty 500 and BSE 500 indices. Its director Ravi Jaipuria and family are #25 among India's richest people (2026). Its director Rajan Bharti Mittal and family are #42 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85110DL2004PLC128319. Its GSTIN is 07AACCG2681C2ZW (Delhi). The company holds 11 GST registrations, of which 8 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 543654 and NSE: MEDANTA.

The company has an authorised share capital of ₹233.52 Cr and a paid-up capital of ₹53.77 Cr. It was formerly known as Global Health Private Limited. It is led by directors including Naresh Trehan (Managing Director) and Pankaj Prakash Sahni (Whole-Time Director).

Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Medanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹4,410.27 Cr, a growth of 19.4% compared to the previous year. For the same year it recorded a net profit of ₹557.19 Cr (net margin 12.6%) and EBITDA of ₹909.42 Cr (EBITDA margin 20.6%). The net worth stands at ₹3,961.57 Cr (up 17% YoY). Total assets are valued at ₹5,340.86 Cr (up 25.9% YoY).

The company has about 10,344 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.

The company is associated with 6 brands, including Lifecard, HotHealth, PrimaryClinic, ReferralNet, Global Health and others. As per MCA filings, the company has open charges of ₹890 Cr and satisfied charges of ₹996.42 Cr on record. Court records list 66 cases involving the company, including 14 filed by the company and 53 filed against it; 16 cases are pending. The company has 19 deals on record (7 funding rounds, 5 market trades, 5 secondary share transfers), with disclosed funding of ₹462.32 Cr; the latest was in June 2026. The company has 39 MSME Form 1 returns on record between 2013 and 2024, listing 34,957 overdue payments to 652 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medanta.org.

Company details

CIN L85110DL2004PLC128319
Registration Number 128319
Incorporation Date 13 August 2004
ROC Delhi
Listing Status Listed - Listed on NSE (MEDANTA); Listed on BSE (543654)
Company Status Active
Compliance Status Active Compliant

CIN history

Global Health has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC128319, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85110DL2004PLC128319Current
U85110DL2004PLC128319Previous
U85110DL2004PTC128319Previous

Recognitions & Rankings of Global Health

India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#193
Valuation
₹31,680 Cr
2023 #211 2022 #302 2021 #384
Stock market indices
Nifty 500 BSE 500

Contact details

Global Health Limited's registered office is in New Delhi, Delhi. Its website is medanta.org. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Medanta – Mediclinic E – 18 Defence Colony, New Delhi, Delhi, India – 110024
  • Industry
    Healthcare, Hospitals

To see the full contact details of Global Health Limited, buy the company report.

Comprehensive company report
Global Health Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Global Health operates multiple associated brands including Lifecard, HotHealth, and PrimaryClinic. Each brand links to its own profile.

BrandDescriptionWebsite
App for managing personal health records and tracking medical progress.lifecard.com
Offers digital platform for healthcare with online bookings, telehealth, and patient forms.hothealth.com
Medical software for efficient practice management and patient care.primaryclinic.com.au
Secure platform for exchanging patient information among healthcare providers.referralnet.com.au
Software applications for Australia's healthcare sector are developed.global-health.com
Chain of multi-super specialty healthcare hospitalsmedanta.org

Business activity

The main business activity of Global Health is hospital and medical care. In detail, this covers hospital activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ1Hospital activities

To see the full business activity and turnover split of Global Health Limited, buy the company report.

Financials of Global Health Limited

FY 2025-26 filings available

Global Health Limited reported revenue of ₹4,410.27 Cr (up 19.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹4,410 Cr
+19.4% YoY
EBITDA
₹909 Cr
+8.7% YoY
Profit After Tax
₹557 Cr
+7.5% YoY
Net Worth
₹3,962 Cr
+17.0% YoY
Total Assets
₹5,341 Cr
+25.9% YoY
Total Debt
₹1,190 Cr
+65.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue4,4103,6923,2752,7102,1671,4471,500
Revenue growth+19.4%+12.7%+20.9%+25.0%+49.8%-3.6%-
EBITDA909836809636458197192
EBITDA margin+20.6%+22.7%+24.7%+23.5%+21.1%+13.6%+12.8%
Profit before tax71564762744928132.4863.87
Net profit55751847832719628.9336.35
Net profit margin+12.6%+14.0%+14.6%+12.1%+9.0%+2.0%+2.4%
EPS (₹)20.7117.9217.8112.167.755.817.36
Balance sheet
Total assets5,3414,2423,8343,6642,8322,3922,354
Net worth3,9623,3862,9062,4281,6161,3821,350
Total debt1,1907188021,1221,109931929
Cash & bank1,1301,1221,1751,278512289250
Net working capital1,1111,0091,0631,146498200174
Cash flow
Cash from operations714624612645311242175
Cash from investing(1,089)(721)(441)(342)(421)(239)(87.07)
Cash from financing272(97.23)(514)346160(80.72)(0.88)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,4691,3041,1591,1211,0991,031931943
Revenue growth (YoY)+33.6%+26.5%+24.5%+18.8%+14.9%+19.7%--
Other income23.6222.1636.7421.7435.7120.4622.9316.02
EBITDA370287244181231247175238
EBITDA margin+25.2%+22.0%+21.0%+16.1%+21.0%+23.9%+18.8%+25.2%
Depreciation70.8068.9866.5261.1949.7345.1149.2548.45
Interest28.0926.6826.7121.5117.1113.7915.0316.28
Profit before tax295213187120200208133189
Tax75.6856.0245.6324.7541.4149.1632.0646.21
Net profit21915714295.03158159101143
EPS (₹)8.205.905.353.545.895.913.775.32
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,7093,2042,9751,9741,7651,2271,472
Revenue growth+15.8%+7.7%+50.7%+11.8%+43.8%-16.6%-
EBITDA744723753422381173218
EBITDA margin+20.1%+22.6%+25.3%+21.4%+21.6%+14.1%+14.8%
Profit before tax65062365935229684.43131
Net profit49649848626421956.70103
Net profit margin+13.4%+15.6%+16.3%+13.4%+12.4%+4.6%+7.0%
EPS (₹)18.4717.1818.119.828.6411.5520.82
Balance sheet
Total assets4,8493,9673,5842,8532,1231,7701,690
Net worth4,0133,4983,0372,4891,7401,4841,423
Total debt68333742428830822818.52
Cash & bank1,0761,0531,1371,145441255219
Net working capital1,0689791,0601,073478223176
Cash flow
Cash from operations573528559431235201193
Cash from investing(931)(638)(519)(257)(313)(250)(45.34)
Cash from financing264(94.49)(379)40497.59(36.67)(55.64)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,2081,079961940926882803812
Revenue growth (YoY)+30.4%+22.3%+19.7%+15.7%+39.4%+44.3%--
Other income25.8924.0635.8124.6638.7942.7325.6719.47
Total expenses918849767801734688658611
EBITDA290230193139193195145202
EBITDA margin+24.0%+21.3%+20.1%+14.8%+20.8%+22.1%+18.1%+24.8%
Depreciation56.1554.6052.2147.8637.4333.4137.9837.35
Interest17.0715.8913.4613.088.885.667.108.46
Profit before tax243183163103185198126175
Tax61.8145.8139.3522.9844.8546.2932.4843.89

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 18 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,4691,3041,1591,1211,0991,031931943
Revenue growth (YoY)+33.6%+26.5%+24.5%+18.8%+14.9%+19.7%--
Other income23.6222.1636.7421.7435.7120.4622.9316.02
EBITDA370287244181231247175238
EBITDA margin+25.2%+22.0%+21.0%+16.1%+21.0%+23.9%+18.8%+25.2%
Depreciation70.8068.9866.5261.1949.7345.1149.2548.45
Interest28.0926.6826.7121.5117.1113.7915.0316.28
Profit before tax295213187120200208133189
Tax75.6856.0245.6324.7541.4149.1632.0646.21
Net profit21915714295.03158159101143
EPS (₹)8.205.905.353.545.895.913.775.32
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue4,4103,6923,2752,7102,1671,4471,500
Revenue growth+19.4%+12.7%+20.9%+25.0%+49.8%-3.6%-
Other income11878.9574.6649.2938.5231.4243.85
Total expenses3,5012,8562,4662,0741,7091,2501,309
Employee cost1,096825735636568466539
EBITDA909836809636458197192
EBITDA margin+20.6%+22.7%+24.7%+23.5%+21.1%+13.6%+12.8%
Depreciation223194173150130123115
Interest90.0574.3583.7886.3386.3272.6456.56
Profit before tax71564762744928132.4863.87
Tax16116614912384.363.6627.54
Net profit55751847832719628.9336.35
Net profit margin+12.6%+14.0%+14.6%+12.1%+9.0%+2.0%+2.4%
EPS (₹)20.7117.9217.8112.167.755.817.36
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital53.7453.7253.7053.6450.6449.5949.35
Reserves & surplus3,9083,3332,8522,3751,5651,3001,268
Shareholders' funds (net worth)3,9623,3862,9062,4281,6161,3821,350
Minority interest22.711.10(0.03)0.000.000.000.00
Secured loans631276310754783568552
Unsecured loans559442492368326363377
Total debt1,1907188021,1221,109931929
Total liabilities5,3414,2423,8343,6642,8322,3922,354
Assets
Gross block5,0473,5783,1462,8772,4582,1732,141
Net block3,7952,5142,2362,0501,7761,6161,703
Capital work in progress132533388327439464382
Investments2.552.710.050.050.050.050.00
Inventories78.9867.1466.8560.3753.3939.7638.52
Sundry debtors411292215194180134149
Cash & bank balances1,1301,1221,1751,278512289250
Loans & advances54.5351.7951.2946.8166.3339.4440.81
Total current assets1,6751,5331,5091,579812502479
Total current liabilities564525446433314302305
Net working capital1,1111,0091,0631,146498200174
Total assets5,3414,2423,8343,6642,8322,3922,354
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash23042576711969.4714860.45
Net cash from operating activities714624612645311242175
Net cash from investing activities(1,089)(721)(441)(342)(421)(239)(87.07)
Net cash from financing activities272(97.23)(514)346160(80.72)(0.88)
Net change in cash(103)(194)(343)64849.97(78.11)87.12
Closing cash1,1301,1221,1751,278512289250
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+19.4%+12.7%+20.9%+25.0%+49.8%-3.6%-
EBITDA growth+8.7%+3.4%+27.1%+38.9%+132.6%+2.8%-
PBT growth+10.5%+3.2%+39.6%+60.1%+763.8%-49.2%-23.3%
Net income growth+7.5%+8.6%+46.2%+66.6%+577.5%-20.4%-
Revenue CAGR (3Y)+17.6%+19.4%+31.3%+21.8%+14.2%+2.5%+2.8%
EBITDA CAGR (3Y)+12.7%+22.2%+60.2%+49.2%+38.5%+16.2%-14.0%
Profitability & leverage
Net income margin+12.6%+13.0%+14.6%+12.0%+9.1%+2.0%+2.4%
Return on capital employed+16.8%+17.9%+19.0%+16.5%+14.1%+4.4%+5.4%
Return on net worth+15.1%+15.3%+17.9%+16.1%+13.1%+2.1%+2.8%
Debt / equity0.260.240.360.550.680.680.65
Long-term debt / equity0.240.200.300.490.610.640.61
Interest cover13.1111.5713.1717.7526.2998.5673.86
Efficiency & per share
Fixed asset turnover1.021.101.091.020.940.670.82
Inventory turnover60.3755.1151.4947.6446.5336.9648.55
Debtors turnover12.5514.5616.0014.4813.8110.239.58
EPS (₹)20.7117.9217.8112.167.755.817.36
Dividend per share (₹)0.500.000.000.000.000.000.00
Book value per share (₹)147.44126.08108.2290.5463.82272.22266.90
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,2081,079961940926882803812
Revenue growth (YoY)+30.4%+22.3%+19.7%+15.7%+39.4%+44.3%--
Other income25.8924.0635.8124.6638.7942.7325.6719.47
Total expenses918849767801734688658611
EBITDA290230193139193195145202
EBITDA margin+24.0%+21.3%+20.1%+14.8%+20.8%+22.1%+18.1%+24.8%
Depreciation56.1554.6052.2147.8637.4333.4137.9837.35
Interest17.0715.8913.4613.088.885.667.108.46
Profit before tax243183163103185198126175
Tax61.8145.8139.3522.9844.8546.2932.4843.89
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,7093,2042,9751,9741,7651,2271,472
Revenue growth+15.8%+7.7%+50.7%+11.8%+43.8%-16.6%-
Other income12690.8190.5947.5935.0428.3543.54
Total expenses2,9652,4822,2221,5521,3841,0541,254
Employee cost989746679533495416522
EBITDA744723753422381173218
EBITDA margin+20.1%+22.6%+25.3%+21.4%+21.6%+14.1%+14.8%
Depreciation17115013486.0987.1787.6498.57
Interest49.8240.6750.7831.8232.8329.2032.54
Profit before tax65062365935229684.43131
Tax15316217288.4677.0427.1428.18
Net profit49649848626421956.70103
Net profit margin+13.4%+15.6%+16.3%+13.4%+12.4%+4.6%+7.0%
EPS (₹)18.4717.1818.119.828.6411.5520.82
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital53.7453.7253.7053.6450.6449.5981.85
Reserves & surplus3,9593,4442,9832,4351,6891,4021,341
Shareholders' funds (net worth)4,0133,4983,0372,4891,7401,4841,423
Secured loans45811417166.4599.860.9618.08
Unsecured loans2252232532212082270.44
Total debt68333742428830822818.52
Total liabilities4,8493,9673,5842,8532,1231,7701,690
Assets
Gross block4,0092,8232,4911,4721,4101,3541,350
Net block2,9031,8611,645810827851929
Capital work in progress12045828074.946.424.163.47
Investments389366362765734626500
Inventories50.9049.0055.3542.2140.0231.6932.26
Sundry debtors387292214173173130148
Cash & bank balances1,0761,0531,1371,145441255219
Loans & advances56.2459.3953.6437.7861.7138.9836.32
Total current assets1,5701,4531,4601,398716455436
Total current liabilities503474400325238233260
Net working capital1,0689791,0601,073478223176
Total assets4,8493,9673,5842,8532,1231,7701,690
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash19039573465.3145.3113239.98
Net cash from operating activities573528559431235201193
Net cash from investing activities(931)(638)(519)(257)(313)(250)(45.34)
Net cash from financing activities264(94.49)(379)40497.59(36.67)(55.64)
Net change in cash(94.16)(205)(339)57720.01(86.25)91.58
Closing cash1,0761,0531,1371,145441255219
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+15.8%+7.7%+50.7%+11.8%+43.8%-16.6%-
EBITDA growth+3.0%-4.0%+78.4%+10.8%+120.2%-20.9%-
PBT growth+4.3%-5.4%+87.3%+18.9%+250.4%-35.5%+35.7%
Net income growth-0.6%+2.6%+84.2%+20.7%+285.5%-44.8%-
Revenue CAGR (3Y)+23.4%+22.0%+34.3%+10.3%+7.0%-3.0%+4.9%
EBITDA CAGR (3Y)+20.8%+23.8%+63.3%+24.5%+38.4%+10.0%+22.6%
Profitability & leverage
Net income margin+13.4%+14.4%+16.4%+13.3%+12.4%+4.7%+7.0%
Return on capital employed+15.9%+17.6%+22.1%+15.4%+16.9%+6.6%+10.3%
Return on net worth+13.2%+14.1%+17.6%+12.5%+13.6%+4.0%+7.7%
Debt / equity0.140.120.130.140.170.080.06
Long-term debt / equity0.130.090.100.110.140.070.05
Interest cover8.697.108.209.4711.1834.2427.13
Efficiency & per share
Fixed asset turnover1.091.211.501.371.280.911.16
Inventory turnover74.2661.4160.9848.0049.2238.3953.00
Debtors turnover10.9412.6815.3711.4011.658.829.42
EPS (₹)18.4717.1818.119.828.6411.5520.82
Dividend per share (₹)0.500.000.000.000.000.000.00
Book value per share (₹)149.34130.22113.1192.8068.70292.65281.74

To see the full year-wise statements and ratios of Global Health Limited, buy the company report.

Board of directors of Global Health Limited

Global Health has 10 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Naresh TrehanManaging Director01 Jun 200719 Years 5 MonthsCurrent
Praveen MahajanDirector29 Oct 20206 Years 0 MonthsCurrent
Rajan Bharti MittalDirector28 Jul 20215 Years 3 MonthsCurrent
Ravi GuptaDirector28 Jul 20215 Years 3 MonthsCurrent
Ravi Kant JaipuriaDirector09 Nov 201610 Years 0 MonthsCurrent
Sunil SachdevaDirector13 Aug 200422 Years 3 MonthsCurrent
Showing 6 of 10 current directors. View all directors

Auditor

Global Health Limited is audited by WALKER CHANDIOK & CO.LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
WALKER CHANDIOK & CO.LLPFY 2023001076N/N500013

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 33.00%, foreign institutional investors hold 9.50%, domestic institutional investors hold 16.90% and retail and other public shareholders hold 40.60%.

Promoters: 33.00%DII (Domestic Institutional): 16.90%FII (Foreign Institutional): 9.50%Retail & Others: 40.60%
Sep 2026
QUARTER
33.00% Promoters
16.90% DII (Domestic Institutional)
9.50% FII (Foreign Institutional)
40.60% Retail & Others
Promoter holding - history
Now 33.00% · Sep 2026High 33.00% · Dec 2025Low 33.00% · Dec 2025
32%32.5%33%33.5%34%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 33.00%Mar 2026: 33.00%Jun 2026: 33.00%Sep 2026: 33.00%33.00%33.00%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters33.00%33.00%33.00%33.00%
Public67.00%67.00%67.00%67.00%

Charges & borrowings

Open charges
₹890 Cr
Satisfied charges
₹996.42 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹450.00 Cr
Others₹150.00 Cr
Hdfc Bank Limited₹150.00 Cr
Yes Bank Limited₹140.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Nov 2025101194652Hdfc Bank Limited₹100 CrOpen
29 Jul 2025101137795Sbicap Trustee Company Limited₹50 CrOpen
27 Mar 2025101076570Others₹100 CrOpen
25 Sep 2024100981675Sbicap Trustee Company Limited₹400 CrOpen
02 Aug 2021100467917Yes Bank Limited₹140 CrOpen

To see the full charge records of Global Health Limited, buy the company report.

Total charge records: 14 View all charges

Deals & funding

Global Health Limited has 19 deals on record (7 funding rounds, 5 market trades, 5 secondary share transfers), with disclosed funding of ₹462.32 Cr; the latest was in June 2026.

Total deals
19
Funding rounds
7
Market trades
5
Secondary share transfers
5
IPO
1
Disclosed funding
₹462.32 Cr

Deals on record (5 of 19)

WhenDealAmountParties
Feb 2024Market trade₹789.08 CrBuyer: Jm Financial Institutional Securities Limited, RJ Corp Limited
Seller: Temasek, Jm Financial Institutional Securities Limited
Nov 2022IPO₹2,205.57 CrInvestors: IPO Shareholders - Global Health Limited, Hdfc Small Cap Fund, Ontario Teachers Pension Plan Board-NP3A-All
Seller: The Carlyle Group, an individual
Mar 2018Funding round₹20 CrInvestors: RJ Corp Limited , Agio Image Limited, 2 individuals
Jan 2015Secondary share transferUndisclosedBuyer: Temasek
Seller: Punj-Lloyd Limited
Jun 2012Funding round₹69.79 CrInvestors: Punj-Lloyd Limited , an individual

To see the full deal history of Global Health Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Global Health Limited was last rated by Crisil on 22 May 2020.

Rating agencyRated onRating
Crisil22 May 2020

To see the full credit ratings and regulatory alerts of Global Health Limited, buy the company report.

MSME payment delays

Global Health Limited has 39 MSME Form 1 returns on record between 2013 and 2024, listing 34,957 overdue payments to 652 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 652)

SupplierAmount dueDue sinceReported on
Midmark (India) Private Limited
an individual supplier
an individual supplier
Microjob Solution Private Limited
an individual supplier

To see the full MSME payment records of Global Health Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Global Health has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Medanta Holdings Private LimitedU74140DL2013PTC250579
Global Health Patliputra Private LimitedU74999DL2015PTC283932
GHL Pharma & Diagnostic Private LimitedU85110DL2022PTC400942

To see the full group structure of Global Health Limited, buy the company report.

Employees & EPFO

Global Health Limited has a workforce of 10,344 employees on its EPFO records as of May 2026, across 6 active EPFO establishments.

Employee count
10,344
Active EPFO establishments
6
Employee growth
-19.6%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2710,344
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Global Health Limited, buy the company report.

GST

Global Health has 11 GST registrations: 8 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
11
Active
8
Cancelled / inactive
3
GSTINStateStatusRegistered on
07AACCG2681C2ZWDelhiActive01 Jul 2017
06AACCG2681C1ZZHaryanaActive01 Jul 2017
09AACCG2681C1ZTUttar PradeshActive01 Jul 2017
10AACCG2681C1ZABiharActive01 Jul 2017

To see the full GST registrations and return filing status of Global Health Limited, buy the company report.

Recent activity

Global Health Limited has 18 board changes on record since 2004: 14 appointments and 4 cessations. The latest: Shonan Purie Trehan was appointed as Director on 13 Mar 2026.

Filing
Global Health Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
Appointed
Shonan Purie Trehan was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 100.00 Cr with Charge ID 101194652 was registered on 14 Nov 2025.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 400.00 Cr registered on 25 Sep 2024 with Charge ID 100981675 was modified on 13 Nov 2025.
AGM
Global Health Limited last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records.
Charges
A charge registered on 12 May 2022 via Charge ID 100579065 with Hdfc Bank Limited was fully satisfied on 17 Sep 2025.
Charges
A charge with Yes Bank Limited of Rs. 140.00 Cr registered on 02 Aug 2021 with Charge ID 100467917 was modified on 05 Sep 2025.
Charges
A charge registered on 06 May 2022 via Charge ID 100577277 with Idbi Trusteeship Services Limited was fully satisfied on 01 Aug 2025.
Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 50.00 Cr with Charge ID 101137795 was registered on 29 Jul 2025.
Charges
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101076570 was registered on 27 Mar 2025.
Ceased
Ratnasami Venkatesh ceased to be Nominee Director.
Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 400.00 Cr with Charge ID 100981675 was registered on 25 Sep 2024.

37 earlier events are in the company report.

News

MEDANTA: Q2 REVENUE 14.7B RUPEES VS 10.99B (YOY)
03 Nov 2026 · Exchange Update
MEDANTA: Q2 CONS NET PROFIT 2.19B RUPEES VS 1.58B (YOY)
03 Nov 2026 · Exchange Update
MEDANTA: Q2 EBITDA 3.7B RUPEES VS 2.31B (YOY); Q2 EBITDA MARGIN 25.19% VS 21.01% (YOY)
03 Nov 2026 · Exchange Update
Global Health Ltd: Receives 10,560.36 Sq. Meters Of Land For ₹165.82 Crores To Build A 350+ Bedded Hospital, Pending Approvals.
28 Sep 2026 · Exchange Update
Global Health: Plans Analyst And Investor Meeting On September 25
22 Sep 2026 · Exchange Update

Frequently asked questions

Global Health is an active public limited company based in New Delhi, Delhi, India. The company works in hospitals, within the healthcare industry. It was incorporated on 13 August 2004 (22+ years old) and is registered under CIN L85110DL2004PLC128319. Listed on BSE: 543654 and NSE: MEDANTA.

Global Health reported revenue of ₹4,410.27 Cr for FY 2025-26 (up 19.4% YoY) based on consolidated financials.

Global Health has 10 current directors:

The latest financial statements of Global Health on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Global Health is 07AACCG2681C2ZW, registered in Delhi. The company has 11 GST registrations in all, of which 8 are active and 3 are cancelled or inactive. Other active GSTINs include 06AACCG2681C1ZZ (Haryana), 09AACCG2681C1ZT (Uttar Pradesh), 10AACCG2681C1ZA (Bihar).

The CIN (Corporate Identification Number) of Global Health is L85110DL2004PLC128319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Global Health is a listed company as per MCA records. Its shares are listed on both BSE (code: 543654) and NSE (symbol: MEDANTA).

Global Health has 66 court cases on record: 14 filed by the company and 53 filed against it. 16 are pending. Most are in the district courts.

Global Health was incorporated on 13 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

Global Health has 19 deals on record (7 funding rounds, 5 market trades, 5 secondary share transfers), with disclosed funding of ₹462.32 Cr; the latest was in June 2026.

Shonan Purie Trehan was appointed as Director on 13 Mar 2026. Ratnasami Venkatesh ceased to be Nominee Director on 14 Nov 2024. Yogesh Kumar Gupta was appointed as CFO on 26 Feb 2024. Global Health has 18 board changes on record in total.